Next big step in biotech Local startup developing new tool for pharmaceutical industry to make gene therapies, vaccines By: Martin Cash Posted: 2:00 AM CST Saturday, Jan. 20, 2024 ...

The global biotechnology machinery makes ample use of microbes, most notably Escherichia coli, as workhorses for the cheap, efficient, and large-scale manufacture of several valuable chemicals.

The DNA of nearly all life on Earth contains many redundancies, and scientists have long wondered whether these redundancies ...

Editor's note: An earlier online version of this article incorrectly referred to E. coli as a virus. This has been corrected. Sign up for our new Business Brief newsletter.

But Bioniche is more than the E. coli vaccine – it has a diverse pipeline of human and animal health products, and recently raised $20-million from a U.S. investment fund.

Certain strains of E. coli are capable of causing severe disease, by rapidly spreading through the human digestive system, wreaking havoc throughout the bloodstream, and eventually damaging the ...

A smartphone-controlled ingestible capsule that can control and allow for two-way communication with gut bacteria in pigs is ...

A few strains, such as E. coli O157:H7 — which commonly behind outbreaks in Canada and U.S. — have been identified as dangerous to people. Photo by Manjurul/iStock/Getty Images ...